Execution of BMP-4-induced apoptosis by p53-dependent ER dysfunction in myeloma and B-cell hybridoma cells

Oncogene

Volumn 25, Issue 25, 2006, Pages 3509-3517

  Fukuda, N ^a   Saitoh, M ^a   Kobayashi, N ^a   Miyazono, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; BMP; ER stress; p53; Signal transduction

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CALCIUM; CASPASE 12; PROTEIN; PROTEIN BAX; PROTEIN P53; PROTEIN PUMA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOSOL; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HYBRIDOMA CELL CULTURE; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BONE MORPHOGENETIC PROTEINS; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; HUMANS; HYBRIDOMAS; IMMUNOBLOTTING; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; MULTIPLE MYELOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33745150407     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209393     Document Type: Article

References (31)

1. Baade Ro T, Utne Holt R, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O et al. (2004). Oncogene 23: 3024-3032.
2. Brosh N, Sternberg D, Honigwachs-Sha'anani J, Lee BC, Shav-Tal Y, Tzehoval E et al. (1995). J Biol Chem 270: 29594-29600.
3. Bruno B, Rotta M, Giaccone L, Massaia M, Bertola A, Palumbo A et al. (2004). Lancet Oncol 5: 430-442.
4. Buckley S, Shi W, Driscoll B, Ferrario A, Anderson K, Warburton D. (2004). Am J Physiol Lung Cell Mol Physiol 286: L81-L86.
5. Cho HJ, Kim JK, Kim KD, Yoon HK, Cho MY, Park YP et al. (2005). Cancer Lett (in press).
6. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, Piccolo S. (2003). Cell 113: 301-314.
7. Franzen A, Heldin NE. (2001). Biochem Biophys Res Commun 285: 773-781.
8. Glozak MA, Rogers MB. (2001). Exp Cell Res 268: 128-138.
9. Grynkiewicz G, Poenie M, Tsien RY. (1985). J Biol Chem 260: 3440-3450.
10. Guo Q, Robinson N, Mattson MP. (1998). J Biol Chem 273: 12341-12351.
11. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y et al. (2004). J Cell Biol 165: 347-356.
12. Hjertner O, Hjorth-Hansen H, Borset M, Seidel C, Waage A, Sundan A. (2001). Blood 97: 516-522.
13. Huang GC, Hobbs S, Walton M, Epstein RJ. (2002). Br J Cancer 86: 1104-1109.
14. Kawamura C, Kizaki M, Ikeda Y. (2002). Leuk Lymphoma 43: 635-639.
15. Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y et al. (2000). Blood 96: 2005-2011.
16. Kiyono M, Shibuya M. (2003). Mol Cell Biol 23: 4627-4636.
17. Nagata S, Nagase H, Kawane K, Mukae N, Fukuyama H. (2003). Cell Death Differ 10: 108-116.
18. Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K et al. (2002). Genes Dev 16: 1345-1355.
19. Nutt LK, Pataer A, Pahler J, Fang B, Roth J, McConkey DJ et al. (2002). J Biol Chem 277: 9219-9225.
20. Oh SJ, Jung JY, Shim SS, Im MY, Kim HD, Chung SY et al. (2000). Mol Cells 10: 275-280.
21. Pan Z, Bhat MB, Nieminen AL, Ma J. (2001). J Biol Chem 276: 32257-32263.
22. Phillips DJ, Brauman JN, Mason AJ, de Kretser DM, Hedger MP. (1999). J Endocrinol 162: 111-116.
23. Reimertz C, Kogel D, Rami A, Chittenden T, Prehn JH. (2003). J Cell Biol 162: 587-597.
24. Shapiro-Shelef M, Calame K. (2004). Curr Opin Immunol 16: 226-234.
25. Sun Y, Leaman DW. (2005). J Biol Chem 280: 15561-15568.
26. Takebayashi-Suzuki K, Funami J, Tokumori D, Saito A, Watabe T, Miyazono K et al. (2003). Development 130: 3929-3939.
27. Takuma K, Yan SS, Stern DM, Yamada K. (2005). J Pharmacol Sci 97: 312-316.
28. Wach S, Schirmacher P, Protschka M, Blessing M. (2001). Oncogene 20: 7761-7769.
29. Yamato K, Hashimoto S, Imamura T, Uchida H, Okahashi N, Koseki T et al. (2001). Oncogene 20: 4383-4392.
30. Yamato K, Hashimoto S, Okahashi N, Ishisaki A, Nonaka K, Koseki T et al. (2000). Exp Cell Res 257: 198-205.
31. Zipori D, Barda-Saad M. (2001). J Leukoc Biol 69: 867-873.